• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活剂及其受体调节胃癌细胞系的侵袭潜能。

Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.

作者信息

Okusa Y, Ichikura T, Mochizuki H, Shinomiya N

机构信息

Department of Surgery I, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.

出版信息

Int J Oncol. 2000 Nov;17(5):1001-5. doi: 10.3892/ijo.17.5.1001.

DOI:10.3892/ijo.17.5.1001
PMID:11029504
Abstract

To assess the role of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) on the invasive potential of cancer cells, in vitro experiments were performed using two human gastric cancer cell lines, NUGC-3 and MKN-28. NUGC-3 cells secreted a higher level of uPA than MKN-28 cells, while the uPAR expression of NUGC-3 cells was lower than that of MKN-28 cells. Both cancer cell lines expressed Met protein and did not express hepatocyte growth factor (HGF). In Matrigel invasion assay, MKN-28 cells demonstrated significantly lower invasion index than NUGC-3 cells. The addition of exogenous uPA significantly increased the invasive activity of MKN-28 cells. The uPA expression in NUGC-3 cells was enhanced by adding conditioned media of fibroblast cells or HGF. These results suggest that uPA promotes the invasive capacity of the uPAR-positive cancer cells, and that stromal cells may play an important role in cancer cell invasion by supplying uPA and/or promoting uPA production.

摘要

为评估尿激酶型纤溶酶原激活剂(uPA)和uPA受体(uPAR)在癌细胞侵袭潜能中的作用,使用两种人胃癌细胞系NUGC-3和MKN-28进行了体外实验。NUGC-3细胞分泌的uPA水平高于MKN-28细胞,而NUGC-3细胞的uPAR表达低于MKN-28细胞。两种癌细胞系均表达Met蛋白,不表达肝细胞生长因子(HGF)。在基质胶侵袭实验中,MKN-28细胞的侵袭指数显著低于NUGC-3细胞。添加外源性uPA显著增加了MKN-28细胞的侵袭活性。通过添加成纤维细胞条件培养基或HGF可增强NUGC-3细胞中的uPA表达。这些结果表明,uPA促进uPAR阳性癌细胞的侵袭能力,并且基质细胞可能通过提供uPA和/或促进uPA产生在癌细胞侵袭中发挥重要作用。

相似文献

1
Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.尿激酶型纤溶酶原激活剂及其受体调节胃癌细胞系的侵袭潜能。
Int J Oncol. 2000 Nov;17(5):1001-5. doi: 10.3892/ijo.17.5.1001.
2
Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.尿激酶型纤溶酶原激活剂的表达与胃癌中的肿瘤血管生成及不良预后相关。
Cancer Sci. 2003 Jan;94(1):43-9. doi: 10.1111/j.1349-7006.2003.tb01350.x.
3
IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.HGF 治疗后,白细胞介素-1β 通过核因子κB刺激胃癌中尿激酶型纤溶酶原激活剂的表达。
Oncol Rep. 2014 May;31(5):2123-30. doi: 10.3892/or.2014.3086. Epub 2014 Mar 12.
4
Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.肝细胞生长因子/c-met信号通路在调控人胃癌中尿激酶型纤溶酶原激活物中的作用:人胃癌的一个潜在治疗靶点
Korean J Intern Med. 2006 Mar;21(1):20-7. doi: 10.3904/kjim.2006.21.1.20.
5
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.白细胞介素-1α通过调节α6β1整合素和尿激酶型纤溶酶原激活剂受体的表达增强胰腺癌细胞的侵袭行为。
BMC Cell Biol. 2006 Feb 20;7:8. doi: 10.1186/1471-2121-7-8.
6
The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.环氧化酶2-前列腺素E2通路对幽门螺杆菌诱导胃癌细胞中尿激酶型纤溶酶原激活物系统的影响
Helicobacter. 2008 Jun;13(3):174-82. doi: 10.1111/j.1523-5378.2008.00597.x.
7
Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.尿激酶型纤溶酶原激活物/尿激酶特异性表面受体的表达以及乳腺癌细胞的基质侵袭需要组成型p38α丝裂原活化蛋白激酶活性。
J Biol Chem. 2000 Apr 21;275(16):12266-72. doi: 10.1074/jbc.275.16.12266.
8
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.靶向人胰腺癌细胞中的尿激酶型纤溶酶原激活物受体可抑制c-Met和胰岛素样生长因子-I受体介导的迁移、侵袭以及小鼠原位肿瘤生长。
Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946.
9
Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.尿激酶型纤溶酶原激活剂及其受体和抑制剂在胃腺癌组织中的表达
J Korean Med Sci. 1996 Feb;11(1):33-7. doi: 10.3346/jkms.1996.11.1.33.
10
Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.胰岛素样生长因子-I介导的人结肠癌细胞迁移和侵袭需要激活c-Met和尿激酶型纤溶酶原激活物受体。
Ann Surg. 2005 May;241(5):748-56; discussion 756-8. doi: 10.1097/01.sla.0000160699.59061.92.

引用本文的文献

1
CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation.CRISPR/Cas9切口酶介导的尿激酶受体基因靶向作用抑制神经母细胞瘤细胞增殖。
Oncotarget. 2018 Jun 29;9(50):29414-29430. doi: 10.18632/oncotarget.25647.
2
MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.MET4表达预示幽门螺杆菌感染的胃癌预后不良。
Cancer Sci. 2017 Mar;108(3):322-330. doi: 10.1111/cas.13146.
3
Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.
骨桥蛋白剪接变异体在胃癌中表现出不同的临床病理特征和生物学功能。
Int J Biol Sci. 2013;9(1):55-66. doi: 10.7150/ijbs.5280. Epub 2012 Dec 20.
4
Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.Tob1 通过激活 Smad4 和抑制 β-连环蛋白信号通路诱导胃癌细胞凋亡并抑制其增殖、迁移和侵袭。
Int J Oncol. 2012 Sep;41(3):839-48. doi: 10.3892/ijo.2012.1517. Epub 2012 Jun 12.
5
Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers.血管内皮生长因子(VEGF)免疫染色阳性可独立预测接受根治性切除的胃癌患者预后不良:一项评估血管生成标志物组的研究结果
J Gastrointest Surg. 2008 Jun;12(6):1005-14. doi: 10.1007/s11605-007-0336-3. Epub 2007 Oct 31.
6
Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.肝细胞生长因子/c-met信号通路在调控人胃癌中尿激酶型纤溶酶原激活物中的作用:人胃癌的一个潜在治疗靶点
Korean J Intern Med. 2006 Mar;21(1):20-7. doi: 10.3904/kjim.2006.21.1.20.
7
Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.尿激酶型纤溶酶原激活剂及其受体在胃成纤维细胞中的表达以及非甾体抗炎药和前列腺素的作用
Dig Dis Sci. 2003 Dec;48(12):2247-56. doi: 10.1023/b:ddas.0000007859.10680.b1.
8
Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.尿激酶型纤溶酶原激活剂的表达与胃癌中的肿瘤血管生成及不良预后相关。
Cancer Sci. 2003 Jan;94(1):43-9. doi: 10.1111/j.1349-7006.2003.tb01350.x.